The big news in US equities markets today is the potential, massive merger in the pharmaceutical industry

Jay Soloff

Argonath Financial

The big news in US equities markets today is the potential, massive merger in the pharmaceutical industry. Valeant Pharmaceuticals (VRX) is offering to buy Allergan (AGN) for a cash-and-stock deal worth just under $46 billion. Valeant is a generic drug company that's been on a buying spree as it moves into specialty medicine. Allergan is known mostly for Botox injections - a $2 billion business last year and rapidly growing. The most noteworthy part of this deal is the involvement of hedge fund manager Bill Ackman and his Pershing Square fund. Ackman had covertly bought up 4.99% of AGN's shares before partnering with Valeant to pursue a hostile takeover. Ackman now owns 9.7% of AGN's outstanding stock. It appears investors (and analysts) believe this is a good deal for both companies with AGN up 16% and VRX up 7% as of this writing. (VIEW LINK)

2 topics

Jay Soloff
Jay Soloff
Research Analyst
Argonath Financial

I'm an investments analyst for a US-based independent investment research firm. My focus is on economics, options, and all types of stocks, but especially tech, Internet, and renewable energy companies. I have experience as a options market...


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Sign In or Join Free to comment